The novel therapy of the medication represents a exciting advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide305713.blogkoo.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-61733965